Phenylalanine hydroxylase (PAH)
Assets acting on this target.
- Class
- Synthetic cofactor (BH4) replacement
- Notes
- mechanism wave 2026-08-24 (PubMed co-occurrence, 217 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/42616575/
By indication
Related mechanisms
Phenylalanine hydroxylase (PAH) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Sapropterin Dihydrochloride (Kuvan)Kuvan | BioMarin Pharmaceutical | small molecule | Approved | Approved in Phenylketonuria |
| Sepiapterin | PTC Therapeutics | small molecule | Approved | Approved in Phenylketonuria |